News
The global prescription lens market is expected to grow at a CAGR of ~5% during the forecast period. Rising prevalence of ...
The global mice model market is set to witness a growth rate of ~9% in the next 5 years. Increasing demand for personalized ...
The Global Pain Management Devices Market is expected to grow at the rate of 9-10 % by 2029. Growing cases of chronic ...
GOTHENBURG, SE / ACCESS Newswire / August 22, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced ...
STOCKHOLM, SE / ACCESS Newswire / August 22, 2025 / Vicore Pharma Holding AB (STO: VICO) ("Vicore"), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs) ...
Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a ...
Partnership aims to scale personalized, root-cause care with AI automation while preserving the patient-first approach of functional medicine. IRVING, TEXAS / ACCESS Newswire / August 21, 2025 / After ...
This announcement has been revised to correct Dr. Alonso Martin's background information. MIAMI BEACH, FLORIDA / ACCESS Newswire / August 21, 2025 / BODYWELLE, a modern aesthetic and longevity clinic ...
Sustained acoustic medicine provided Lia Winter with a way to recover quickly without the need for invasive surgery to repair a herniated cervical disc. TRUMBULL, CONNECTICUT / ACCESS Newswire / ...
VANCOUVER, BC / ACCESS Newswire / August 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is issuing the following press release to clarify its disclosure ...
AUSTIN, TX / ACCESS Newswire / August 21, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum ...
Aiming to Enter Clinical Trials for Residual & Metastatic HCC in 2026 MIAMI, FL and LANSING, MI / ACCESS Newswire / August 21, 2025 / NAYA Therapeutics ("NAYA"), a clinical-stage biopharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results